Article
Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
EBioMedicine - 1 Mar 2016
Xu Zhi-Peng, Yang Su-Lian, Zhao Shi, Zheng Cheng-Hong, Li Hong-Hua, Zhang Yao, Huang Rong-Xi, Li Meng-Zhu, Gao Yuan, Zhang Shu-Juan, Zhan Pei-Yan, Zhang Li-Fang, Deng Lin, Wei Sheng, Liu Yan-Chao, Ye Jing-Wang, Ren Hu-Jun, Li Na, Kong Cai-Xia, Wang Xin, Fang Lin, Zhou Qiu-Zhi, Jiang Hong-Wei, Li Jing-Rong, Wang Qun, Ke Dan, Liu Gong-Ping, Wang Jian-Zhi
Abstract excerpt
BACKGROUND: Both type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD) are common age-associated disorders and T2DM patients show an increased risk to suffer from AD, however, there is currently no marker to identify who in T2DM populations will develop AD. Since glycogen synthase kinase-3β (GSK-3β) activity, ApoE genotypes and olfactory function are involved in both T2DM and AD pathogenesis, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
